Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Keros Therapeutics
KROS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$55.80
0
0.00%
Pre-Market: Sep 20, 4:04 PM EDT
15 minutes delayed
Get Report
Comment
Keros Therapeutics (KROS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Keros Therapeutics (NASDAQ:KROS) Stock
Keros Therapeutics Stock (NASDAQ: KROS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, September 23, 2024
Guggenheim Initiates Coverage On Keros Therap...
Benzinga Newsdesk
Thursday, September 12, 2024
B of A Securities Maintains Buy on Keros Ther...
Benzinga Newsdesk
Tuesday, September 03, 2024
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Keros Therapeutics shares are trading higher ...
Benzinga Newsdesk
Keros Therapeutics Has Closed Screening For T...
Benzinga Newsdesk
Wednesday, August 07, 2024
Keros Therapeutics Q2 EPS $(1.25) Misses $(1....
Benzinga Newsdesk
Tuesday, June 25, 2024
Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth
Vandana Singh
Oppenheimer Initiates Coverage On Keros Thera...
Benzinga Newsdesk
Tuesday, June 18, 2024
Truist Securities Maintains Buy on Keros Ther...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Keros T...
Benzinga Newsdesk
Monday, June 17, 2024
Keros Therapeutics Appointed Jasbir S. Seehra...
Benzinga Newsdesk
Keros Therapeutics Presented Additional Data ...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Keros T...
Benzinga Newsdesk
Wednesday, May 08, 2024
Keros Therapeutics Q1 EPS $(1.21) Beats $(1.3...
Benzinga Newsdesk
Wednesday, March 27, 2024
Piper Sandler Maintains Overweight on Keros T...
Benzinga Newsdesk
Thursday, March 14, 2024
Keros Therapeutics Announces FDA Fast Track D...
Benzinga Newsdesk
Wednesday, March 13, 2024
Truist Securities Reiterates Buy on Keros The...
Benzinga Newsdesk
Friday, March 01, 2024
HC Wainwright & Co. Reiterates Buy on Keros T...
Benzinga Newsdesk
Wednesday, February 28, 2024
Keros Therapeutics Q4 EPS $(1.34) Beats $(1.37) Estimate
Happy Mohamed
Thursday, January 04, 2024
Keros Therapeutics shares are trading higher....
Benzinga Newsdesk
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Keros Therapeutics Prices Upsized $140M Publi...
Benzinga Newsdesk
Wednesday, January 03, 2024
Keros Therapeutics Announces Proposed $120M O...
Benzinga Newsdesk
Keros Therapeutics Announces Plans To Develop...
Benzinga Newsdesk
Monday, December 11, 2023
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Keros Therapeutics shares are trading lower a...
Benzinga Newsdesk
Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Keros Therapeutics Showcases Phase 2 Trials o...
Benzinga Newsdesk
Friday, December 08, 2023
Wells Fargo Initiates Coverage On Keros Thera...
Benzinga Newsdesk
Monday, November 13, 2023
Wedbush Reiterates Outperform on Keros Therap...
Benzinga Newsdesk
Monday, November 06, 2023
Keros Therapeutics Q3 EPS $(1.33) Beats $(1.3...
Benzinga Newsdesk
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Keros Therapeutics Presents Preclinical Data ...
Benzinga Newsdesk
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Thursday, August 31, 2023
Wedbush Reiterates Outperform on Keros Therap...
Benzinga Newsdesk
Wednesday, August 09, 2023
HC Wainwright & Co. Reiterates Buy on Keros T...
Benzinga Newsdesk
Tuesday, August 08, 2023
Wedbush Reiterates Outperform on Keros Therap...
Benzinga Newsdesk
Monday, August 07, 2023
HC Wainwright & Co. Reiterates Buy on Keros T...
Benzinga Newsdesk
Keros Therapeutics Q2 EPS $(1.27) Beats $(1.3...
Benzinga Newsdesk
Monday, July 31, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Benzinga Insights
Wedbush Initiates Coverage On Keros Therapeut...
Benzinga Newsdesk
Wednesday, July 26, 2023
Where Keros Therapeutics Stands With Analysts
Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
Benzinga Insights
B of A Securities Initiates Coverage On Keros...
Benzinga Newsdesk
Monday, July 24, 2023
The FDA Clears Keros Therapeutics' Investigat...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch